Shares of Star Health and Allied Insurance Company slipped more than 1 per cent on Friday, 24 July 2026, after the company's June-quarter shareholding pattern revealed a sharp decline in Rekha Jhunjhunwala's direct stake. The move, however, was not a market sale or a promoter exit — it was a succession-linked transmission and an off-market transfer of 7.82 crore equity shares to Sitara Partners LLP, a promoter entity in which Rekha Jhunjhunwala is a Designated Partner.

What the Transfer Involved

The transaction followed regulatory clearance from the Insurance Regulatory and Development Authority of India (IRDAI) for the transmission of 8.28 crore shares previously held by the late investor Rakesh Jhunjhunwala under the probate of his estate. Of these, 7.82 crore shares were transferred off-market to Sitara Partners LLP on 24 June 2026. Following the transfer, the LLP held 13.29 per cent of Star Health's equity share capital.

The company was categorical that the transaction did not involve any open-market sale, third-party disposal, or reduction in the promoter group's overall holding. The restructuring is best understood as an estate consolidation — moving inherited shares from an individual's name into a promoter-controlled entity.

The Jhunjhunwala Family's History With Star Health

The family's association with Star Health predates the insurer's stock market debut. At the time of the company's 2021 initial public offering (IPO), the late Rakesh Jhunjhunwala held a 14.98 per cent stake, as disclosed in the red herring prospectus (RHP).

Since then, the family's shareholding has seen multiple shifts. Rekha Jhunjhunwala raised her personal stake from 3.04 per cent in the September quarter of FY26 to 15.57 per cent by the December quarter, before the June-quarter transfer sharply reduced her direct holding. The broader promoter group's stake, however, remains intact.

Rekha Jhunjhunwala's Broader Portfolio

According to the latest corporate shareholding disclosures, Rekha Jhunjhunwala holds publicly disclosed investments in 26 listed companies, with a combined portfolio value of more than ₹47,085.4 crore. Her position in Star Health — now largely routed through Sitara Partners LLP — remains among the more closely tracked holdings given the family's long-standing connection to the insurer.

Stock Performance and What to Watch

Star Health shares have staged a substantial recovery over the past year after touching a 52-week low of ₹416.05 in July 2025. The stock subsequently rallied nearly 50 per cent to hit a 52-week high of ₹623.45 on 14 July 2026. Friday's dip appears to reflect market misreading of the shareholding disclosure rather than any fundamental change in promoter intent. Investors and analysts will watch whether further estate-related transfers are pending, and whether the LLP structure signals any longer-term succession planning for the family's insurance holdings.